Log in to search using one of your social media accounts:

 

Change in fear of falling in Parkinson's disease: a two-year prospective cohort study - Gazibara T, Tepavcevic DK, Svetel M, Tomi ć A, Stankovic I, Kostić VS, Pekmezović T.
BACKGROUND: Fear of falling in Parkinson's disease (PD) has been suggested as predictor of future falling. The purpose of this study was to compare fear of falling score after two years of follow-up with those observed at baseline and to assess factors ass... (Source: SafetyLit)
Source: SafetyLit - November 25, 2017 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

Cognitive reserve as a variable impacting the effectiveness of rehabilitation on balance in Parkinson's disease - Piccinini G, Imbimbo I, Ricciardi D, Coraci D, Santilli C, Lo Monaco MR, Loreti C, Vulpiani MC, Silveri MC, Padua L.
BACKGROUND: Cognitive reserve (CR) can be considered an active expression of brain resilience in response to damage. Several studies have shown the influence of CR on cognitive impairment and its relationship with cognitive function in Parkinson's disease ... (Source: SafetyLit)
Source: SafetyLit - November 25, 2017 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

Medical News Today: Neurodegeneration: New cell death mechanism revealed
New research uncovers the mechanism by which brain cells die in neurodegenerative conditions such as dementia and Parkinson's disease. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 23, 2017 Category: Consumer Health News Tags: Neurology / Neuroscience Source Type: news

Neurodegeneration: New cell death mechanism revealed
New research uncovers the mechanism by which brain cells die in neurodegenerative conditions such as dementia and Parkinson's disease. (Source: Parkinson's Disease News From Medical News Today)
Source: Parkinson's Disease News From Medical News Today - November 23, 2017 Category: Neurology Tags: Neurology / Neuroscience Source Type: news

Featured Review: Virtual reality for stroke rehabilitation
Many people after having a stroke have difficulty moving, thinking, and sensing. This often results in problems with everyday activities such as writing, walking, and driving. Virtual reality and interactive video gaming therapy  involves using computer-based programs designed to simulate real-life objects and events. This may have some advantages over traditional  therapy approaches as they can give people an opportunity to practice everyday activities that are not or cannot be practiced within the hospital environment and patients may spend more time in therapy as the activity might be more motivating.A te...
Source: Cochrane News and Events - November 23, 2017 Category: Information Technology Authors: Muriah Umoquit Source Type: news

Dementia: Unprecedented detail of brain damage revealed
Scientists use cutting-edge technology to show how Lewy body dementia affects more than 1 million synapses, the tiny connections between neurons. (Source: Parkinson's Disease News From Medical News Today)
Source: Parkinson's Disease News From Medical News Today - November 22, 2017 Category: Neurology Tags: Alzheimer's / Dementia Source Type: news

Study reveals new mechanisms of cell death in neurodegenerative disorders
(King's College London) Researchers at King's College London have discovered new mechanisms of cell death, which may be involved in debilitating neurodegenerative disorders, such as Alzheimer's disease and Parkinson's disease. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - November 22, 2017 Category: International Medicine & Public Health Source Type: news

MRI reveals brain changes caused by depression, anxiety
Major depressive disorder and social anxiety disorder lead to abnormal modifications...Read more on AuntMinnie.comRelated Reading: fMRI reveals that 'magic mushrooms' reduce depression fMRI links brain disruptions to Parkinson's hallucinations fMRI locates brain region tied to sleep-related depression fMRI scans may help choose depression treatment strategy fMRI shows emotional areas of brain (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 21, 2017 Category: Radiology Source Type: news

Controlling diabetes with your phone might be possible someday
(Rutgers University) Nerve-stimulating procedures from ancient traditional acupuncture and the more modern electroacupuncture and neuromodulation relieves chronic pain, pelvic disorders and Parkinson's disease, and can be advantageous for treating inflammatory disorders like arthritis and deadly infections like sepsis. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 21, 2017 Category: International Medicine & Public Health Source Type: news

Man feels twin's Parkinson's tremors with SymPulse device
A new 'tele-empathy' device allows Pat Smerdon of Vancouver to experience the same Parkinson's tremors that his twin brother, Jim, struggles with every day. (Source: the Mail online | Health)
Source: the Mail online | Health - November 20, 2017 Category: Consumer Health News Source Type: news

For Parkinson's Patients Like Jesse Jackson, Artificial Intelligence Shows Real Promise
US civil rights activist Jesse Jackson disclosed that he has been diagnosed with Parkinson ’s disease. Unfortunately for Jackson, and more than 10 million worldwide living with Parkinson's, there's no cure. However, a new partnership between AstraZeneca and Berg believes AI will be able to prevent it (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - November 20, 2017 Category: Pharmaceuticals Authors: Nicole Fisher, Contributor Tags: NASDAQ:AZN NASDAQ:BERG NASDAQ:GSK Source Type: news

For Parkinson's Patients Like Jesse Jackson, Artificial Intelligence Shows Real Promise
US civil rights activist Jesse Jackson disclosed that he has been diagnosed with Parkinson ’s disease. Unfortunately for Jackson, and more than 10 million worldwide living with Parkinson's, there's no cure. However, a new partnership between AstraZeneca and Berg believes AI will be able to prevent it (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - November 20, 2017 Category: Pharmaceuticals Authors: Nicole Fisher, Contributor Tags: NASDAQ:AZN NASDAQ:BERG NASDAQ:GSK Source Type: news

Acorda Therapeutics scraps Parkinson's drug after deaths
(Reuters) - Acorda Therapeutics Inc said on Monday it would stop developing its Parkinson's disease drug, less than a week after the company reported deaths in key studies testing the treatment. (Source: Reuters: Health)
Source: Reuters: Health - November 20, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Rev. Jesse Jackson In A Battle Against Parkinson's Disease
The 76 year old American civil rights activist, Baptist minister, and politician just revealed that in 2015 he was diagnosed with Parkinson's Disease (PD). Here's what the diagnosis means. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - November 18, 2017 Category: Pharmaceuticals Authors: Bruce Y. Lee, Contributor Source Type: news

Rev. Jesse Jackson In A Battle Against Parkinson's Disease
The 76 year old American civil rights activist, Baptist minister, and politician just revealed that in 2015 he was diagnosed with Parkinson's Disease (PD). Here's what the diagnosis means. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - November 18, 2017 Category: Pharmaceuticals Authors: Bruce Y. Lee, Contributor Source Type: news

Parkinson's Hits Earlier With Higher Genetic Burden of LRRK2 Variants Parkinson's Hits Earlier With Higher Genetic Burden of LRRK2 Variants
Increases in the genetic burden of LRRK2 risk variants are associated with an earlier age at onset of Parkinson's disease (PD) in Asians, a new study suggests.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 17, 2017 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Jesse Jackson reveals he has Parkinson's disease
Rev. Jesse Jackson disclose publicly that he has been seeking outpatient care for two years for Parkinson's disease and plans to "dedicate" himself to physical therapy. (Source: CBC | Health)
Source: CBC | Health - November 17, 2017 Category: Consumer Health News Tags: News/World Source Type: news

Jesse Jackson Announces He Has Parkinson ’ s Disease
The longtime civil rights leader said he plans to make “ lifestyle changes ” but will not allow the disease to interfere with his advocacy work. (Source: NYT Health)
Source: NYT Health - November 17, 2017 Category: Consumer Health News Authors: NIRAJ CHOKSHI Tags: Civil Rights Movement (1954-68) Parkinson's Disease Jackson, Jesse L Source Type: news

Parkinson's disease: What you need to know in wake of Jesse Jackson's diagnosis
Answers to some of the more common questions about this disease. (Source: ABC News: Health)
Source: ABC News: Health - November 17, 2017 Category: Consumer Health News Tags: Health Source Type: news

Rev. Jesse Jackson: 'I Have Parkinson's'
The civil rights leader was diagnosed in 2015. (Source: WebMD Health)
Source: WebMD Health - November 17, 2017 Category: Consumer Health News Source Type: news

Jesse Jackson diagnosed with Parkinson's disease
The civil rights leader said family and friends noticed a change in him about three years ago (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - November 17, 2017 Category: Consumer Health News Source Type: news

Jesse Jackson diagnosed with Parkinson's disease
Civil rights activist the Rev. Jesse Jackson said Friday that he has been diagnosed with Parkinson's disease. A neurological disorder with no cure, Parkinson's can cause tremors, stiffness and difficulty balancing, walking and coordinating movement. (Source: CNN.com - Health)
Source: CNN.com - Health - November 17, 2017 Category: Consumer Health News Source Type: news

Mileha Soneji: Can Simple Innovations Improve The Lives of Parkinson's Patients?
When designer Mileha Soneji's uncle got Parkinson's, his quality of life deteriorated rapidly. Mileha couldn't cure her uncle's disease, so she designed simple ways to improve his everyday life.(Image credit: TEDxDelft) (Source: NPR Health and Science)
Source: NPR Health and Science - November 17, 2017 Category: Consumer Health News Authors: NPR/TED Staff Source Type: news

Ask Well: What Is Parkinsonism?
The stiffness, slowness and shuffling of the feet that are classic features of Parkinson ’ s disease can also be caused by other disorders. (Source: NYT Health)
Source: NYT Health - November 17, 2017 Category: Consumer Health News Authors: RONI CARYN RABIN Tags: Parkinson's Disease Brain Dopamine Source Type: news

Acorda reports five deaths in Parkinson's trial, shares plunge
(Reuters) - Acorda Therapeutics Inc said on Wednesday five people died in its Parkinson's disease drug trials, and it would stop enrolling new patients in two long-term safety studies, sending its shares down 34 percent in early trade. (Source: Reuters: Health)
Source: Reuters: Health - November 15, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Acorda halts enrollment in Parkinson's trial, shares plunge
(Reuters) - Acorda Therapeutics Inc's shares plunged 34 percent on Wednesday after the drugmaker said it had paused enrolling patients in two key trials testing its Parkinson's disease drug following patient deaths. (Source: Reuters: Health)
Source: Reuters: Health - November 15, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Parkinson's pandemic is on the horizon, experts warn
There are now about 6.9 million Parkinson's patients worldwide and, by 2040, the number will grow to 14.2 million as the population ages, experts wrote in a commentary piece. (Source: the Mail online | Health)
Source: the Mail online | Health - November 14, 2017 Category: Consumer Health News Source Type: news

Drug maker led by Genenexers, and targeting Alzheimer's, Parkinson's and ALS, seeks $100 million IPO
A band of former Genentech employees has raised $350 million and gathered a portfolio of drugs targeting neurodegenerative diseases such as Alzheimer's, Parkinson's and Lou Gehrig's disease in just two and a half years — and now it's zeroing in on a $100 million initial public offering. Denali Therapeutics Inc. is the first sizable IPO by a Bay Area life sciences company this year and signals the resurgent hope in the industry that drugs can be found to tackle some of the toughest brain-wasting… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - November 14, 2017 Category: American Health Authors: Ron Leuty Source Type: news

Drug maker led by Genenexers, and targeting Alzheimer's, Parkinson's and ALS, seeks $100 million IPO
A band of former Genentech employees has raised $350 million and gathered a portfolio of drugs targeting neurodegenerative diseases such as Alzheimer's, Parkinson's and Lou Gehrig's disease in just two and a half years — and now it's zeroing in on a $100 million initial public offering. Denali Therapeutics Inc. is the first sizable IPO by a Bay Area life sciences company this year and signals the resurgent hope in the industry that drugs can be found to tackle some of the toughest brain-wasting… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 14, 2017 Category: Biotechnology Authors: Ron Leuty Source Type: news

Parkinson ’s Disease: A Looming Pandemic
New research shows that the number of people with Parkinson ’s disease will soon grow to pandemic proportions. In a commentary appearing today in the journal JAMA Neurology, University of Rochester Medical Center neurologist Ray Dorsey, M.D. and Bastiaan Bloem, M.D., Ph.D., with Radboud University Medical Center in the Netherlands, argue that the medical community must be mobilized to respond to this impending public health threat. (Source: University of Rochester Medical Center Press Releases)
Source: University of Rochester Medical Center Press Releases - November 13, 2017 Category: Universities & Medical Training Authors: University of Rochester Medical Center Source Type: news

Glasses-type wearable computer displays: usability considerations examined with a 3D glasses case study - Chang J, Moon SK, Jung K, Kim W, Parkinson M, Freivalds A, Simpson TW, Baik SP.
This study presents usabilityconsiderations and solutions for the design of glasses-type wearable computer displays and examines their effectiveness in a case study.Design countermeasures were investigated by a four-step design process: (1) preliminary des... (Source: SafetyLit)
Source: SafetyLit - November 13, 2017 Category: International Medicine & Public Health Tags: Distraction, Fatigue, Chronobiology, Vigilance, Workload Source Type: news

Gait and cognition in parkinson's disease: cognitive impairment is inadequately reflected by gait performance during dual task - Ga ßner H, Marxreiter F, Steib S, Kohl Z, Schlachetzki JCM, Adler W, Eskofier BM, Pfeifer K, Winkler J, Klucken J.
INTRODUCTION: Cognitive and gait deficits are common symptoms in Parkinson's disease (PD). Motor-cognitive dual tasks (DTs) are used to explore the interplay between gait and cognition. However, it is unclear if DT gait performance is indicative for cognit... (Source: SafetyLit)
Source: SafetyLit - November 13, 2017 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

Risky decision-making and affective features of impulse control disorders in Parkinson's disease - Martini A, Ellis SJ, Grange JA, Tamburin S, Dal Lago D, Vianello G, Edelstyn NMJ.
Impulse control disorders (ICDs) in Parkinson's disease (PD) are considered dopaminergic treatment side effects. Cognitive and affective factors may increase the risk of ICD in PD. The aim is to investigate risky decision-making and associated cognitive pr... (Source: SafetyLit)
Source: SafetyLit - November 13, 2017 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

Prediction of falls in subjects suffering from Parkinson's disease, multiple sclerosis and stroke - Beghi E, Gervasoni E, Pupillo E, Bianchi E, Montesano A, Aprile I, Agostini M, Rovaris M, Cattaneo D.
OBJECTIVE: To compare the risk of falls and fall predictors in patients with Parkinson's disease (PD), multiple sclerosis (MS) and stroke using the same study design. DESIGN: Multicenter prospective cohort study. SETTING: Three [masked] institution... (Source: SafetyLit)
Source: SafetyLit - November 13, 2017 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

Depression and associated factors in nondemented Chinese patients with Parkinson's disease - Zhu J, Lu L, Pan Y, Shen B, Xu S, Hou Y, Zhang X, Zhang L.
This study aimed to estimate the prevalence and identify potential risk factors influencing depression in 519 consecutive nondemented Chinese PD p... (Source: SafetyLit)
Source: SafetyLit - November 13, 2017 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

Biomarker may predict early Alzheimer's disease
(Sanford-Burnham Prebys Medical Discovery Institute) Researchers at SBP have identified a peptide that could lead to the early detection of Alzheimer's disease (AD). The discovery, published in Nature Communications, may also provide a means of homing drugs to diseased areas of the brain to treat AD, Parkinson's disease, as well as glioblastoma, brain injuries and stroke. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 10, 2017 Category: International Medicine & Public Health Source Type: news

New research to target air pollution as a potential trigger for Parkinson's
(Van Andel Research Institute) The Department of Defense has awarded a multi-institutional team of scientists a series of grants totaling $4.37 million to investigate the potential role of airborne pollutants as triggers of Parkinson's disease via the nose. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 9, 2017 Category: International Medicine & Public Health Source Type: news

UCLA helps many to live long and prosper
In Westwood, more than 100 faculty experts from 25 departments have embarked on anall-encompassing push to cut the health and economic impacts of depression in half by the year 2050. The mammoth undertaking will rely on platforms developed by the new Institute for Precision Health, which will harness the power of big data and genomics to move toward individually tailored treatments and health-promotion strategies.On the same 419 acres of land, researchers across the spectrum, from the laboratory bench to the patient bedside, are ushering in a potentially game-changing approach to turning the body ’s immune defenses a...
Source: UCLA Newsroom: Health Sciences - November 9, 2017 Category: Universities & Medical Training Source Type: news

Sodium Oxybate Promising for Parkinson ’ s, Daytime Sleepiness
Improvements in subjective sleep quality, objectively measured slow - wave sleep duration (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - November 8, 2017 Category: Respiratory Medicine Tags: Family Medicine, Geriatrics, Internal Medicine, Neurology, Pharmacy, Pulmonology, Journal, Source Type: news

New technologies can SMELL sickness
Two groups of scientists have developed experimental technologies that can detect disease including malaria, Parkinson's and cancer using the smell of your breath. (Source: the Mail online | Health)
Source: the Mail online | Health - November 7, 2017 Category: Consumer Health News Source Type: news

New treatment direction sought in Parkinson's by blocking the blocker of a natural protection
(Medical College of Georgia at Augusta University) Oxidative stress plays a big role in the brain cell loss that occurs in Parkinson's disease. Now scientists have their sights on a protein that inhibits one of the body's natural protections against it. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 6, 2017 Category: International Medicine & Public Health Source Type: news

Comedy writer with Parkinson's tries stand-up comedy
Paul Mayhew-Archer wanted to try stand-up comedy before his condition deteriorated. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - November 5, 2017 Category: Consumer Health News Source Type: news

OHSU study validates deep brain surgery while asleep for Parkinson's patients
Most brain surgeons in the U.S. perform the procedure with patients awake the whole time. Not at OHSU.Most surgeons perform deep brain stimulation to ease the effects of Parkinson ’s disease while the patient is awake. Not at Oregon Health& Science University. OHSU neurologists stopped doing awake surgeries in January 2011. They pioneered a technique to accurately map the brain before and during the procedure, allowing the patient to remain asleep with general anesthesia all the while. With DBS, surgeons implant electrodes into specific areas of the brain that control movement in order to improve motor function a...
Source: bizjournals.com Health Care News Headlines - November 3, 2017 Category: Health Management Authors: Elizabeth Hayes Source Type: news

OHSU study validates deep brain surgery while asleep for Parkinson's patients
Most brain surgeons in the U.S. perform the procedure with patients awake the whole time. Not at OHSU.Most surgeons perform deep brain stimulation to ease the effects of Parkinson ’s disease while the patient is awake. Not at Oregon Health& Science University. OHSU neurologists stopped doing awake surgeries in January 2011. They pioneered a technique to accurately map the brain before and during the procedure, allowing the patient to remain asleep with general anesthesia all the while. With DBS, surgeons implant electrodes into specific areas of the brain that control movement in order to improve motor function a...
Source: bizjournals.com Health Care:Biotechnology headlines - November 3, 2017 Category: Biotechnology Authors: Elizabeth Hayes Source Type: news

Biomechanical and human behavior assessment using virtual reality to challenge balance and posture for the elderly and patients with Parkinson's disease - Muhla F, Clanch é F, Rose C, Cosson A, Gauchard G.
[Abstract unavailable] Language: en... (Source: SafetyLit)
Source: SafetyLit - November 3, 2017 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

Scratching the surface of mature monocytes...and coming up with CXCR7
(Federation of American Societies for Experimental Biology) New research published online in the Journal of Leukocyte Biology showed for the first time that mature monocytes (a specific type of white blood cell) express the CXCR7 receptor on their surface. This receptor may be a therapeutic target for controlling inflammation in the brain associated with diseases like multiple sclerosis, Parkinson's and AIDS. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 3, 2017 Category: International Medicine & Public Health Source Type: news

Focused ultrasound improves Parkinson's tremors
A new trial found that Parkinson's patients who received MRI-guided focused...Read more on AuntMinnie.comRelated Reading: fMRI links brain disruptions to Parkinson's hallucinations DWI-MRI shows vision changes could predict Parkinson's DTI-MRI sheds light on Parkinson's disease Real-time MRI could guide Parkinson's therapy FDG-PET predicts survival in Parkinsonian syndrome (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 31, 2017 Category: Radiology Source Type: news

Downing Street recognition for Parkinson's researcher
Dr Emily Henderson, a University of Bristol Honorary Consultant Senior Lecturer, and Consultant at the Royal United Hospitals in Bath, met the Prime Minister Theresa May at a Parkinson's UK charity reception at Downing Street yesterday [Monday 30 October] in recognition of her research into Parkinson's, and to mark the 200-year anniversary since James Parkinson first described the condition. (Source: University of Bristol news)
Source: University of Bristol news - October 31, 2017 Category: Universities & Medical Training Tags: Health, Research; Faculty of Health Sciences, Faculty of Health Sciences, Bristol Medical School, Institutes, Bristol Population Health Science Institute; Press Release Source Type: news

Falls in Parkinson's disease: a complex and evolving picture - Fasano A, Canning CG, Hausdorff JM, Lord S, Rochester L.
Falls are a major determinant of poor quality of life, immobilization, and reduced life expectancy in people affected by Parkinson's disease (PD) and in older adults more generally. Although many questions remain, recent research has advanced the understan... (Source: SafetyLit)
Source: SafetyLit - October 30, 2017 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news

A prospective study of falls in relation to freezing of gait and response fluctuations in Parkinson's disease - Okuma Y, Silva de Lima AL, Fukae J, Bloem BR, Snijders AH.
INTRODUCTION: Falls are a disabling feature of Parkinson's disease (PD). In this prospective study we investigated: (1) in which motor state patients with PD fallmost often; and (2) whether freezing of gait (FOG) and dyskinesias contribute to falls. ... (Source: SafetyLit)
Source: SafetyLit - October 30, 2017 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news